Riken Vitamin Co., Ltd. (TYO:4526)
Japan · Delayed Price · Currency is JPY 3,565.00
-80.00 (-2.19%)
Nov 6, 2026, 3:30 PM JST
Riken Vitamin Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 103,502 | 83,827 | 72,261 | 78,257 | 63,097 | 55,011 | |
Market Cap Growth | 24.66% | 16.01% | -7.66% | 24.03% | 14.70% | 22.90% |
Enterprise Value | 93,043 | 74,371 | 64,261 | 70,809 | 60,307 | 59,950 |
Last Close Price | 3645.00 | 2824.42 | 2291.53 | 2353.21 | 1698.78 | 1434.71 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.79 | 11.92 | 7.70 | 8.94 | 9.84 | 2.55 |
Forward PE | 12.75 | 13.43 | 8.58 | 10.30 | 12.32 | 12.32 |
PS Ratio | 1.06 | 0.87 | 0.76 | 0.86 | 0.71 | 0.69 |
PB Ratio | 1.23 | 1.00 | 0.91 | 1.02 | 0.88 | 0.83 |
P/TBV Ratio | 1.25 | 1.02 | 0.92 | 1.03 | 0.89 | 0.84 |
P/FCF Ratio | 94.75 | 76.21 | 22.48 | 9.89 | 11.03 | 15.40 |
P/OCF Ratio | 17.48 | 14.06 | 9.16 | 7.49 | 8.05 | 8.06 |
PEG Ratio | - | 1.22 | 1.22 | 1.22 | 1.22 | 1.22 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.96 | 0.77 | 0.67 | 0.77 | 0.68 | 0.76 |
EV/EBITDA Ratio | 7.93 | 6.42 | 5.39 | 5.58 | 5.56 | 6.26 |
EV/EBIT Ratio | 13.82 | 10.78 | 7.37 | 7.56 | 8.46 | 10.26 |
EV/FCF Ratio | 85.24 | 67.61 | 19.99 | 8.95 | 10.54 | 16.78 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.13 | 0.21 | 0.20 | 0.26 |
Debt / EBITDA Ratio | - | 0.62 | 0.83 | 1.26 | 1.34 | 1.83 |
Debt / FCF Ratio | - | 6.49 | 3.09 | 2.03 | 2.54 | 4.91 |
Net Debt / Equity Ratio | -0.12 | -0.15 | -0.16 | -0.10 | -0.06 | 0.00 |
Net Debt / EBITDA Ratio | -0.89 | -1.12 | -1.04 | -0.58 | -0.42 | 0.02 |
Net Debt / FCF Ratio | - | -11.75 | -3.85 | -0.93 | -0.80 | 0.07 |
Asset Turnover | - | 0.84 | 0.83 | 0.82 | 0.85 | 0.76 |
Inventory Turnover | - | 3.19 | 3.37 | 3.39 | 3.75 | 3.66 |
Quick Ratio | 2.18 | 2.20 | 2.09 | 1.49 | 2.08 | 1.98 |
Current Ratio | 3.51 | 3.41 | 3.11 | 2.14 | 3.07 | 2.90 |
Return on Equity (ROE) | - | 8.66% | 12.05% | 11.83% | 9.31% | 38.16% |
Return on Assets (ROA) | - | 3.76% | 4.71% | 5.23% | 4.29% | 3.49% |
Return on Invested Capital (ROIC) | 9.40% | 6.91% | 9.47% | 10.13% | 8.72% | 9.85% |
Return on Capital Employed (ROCE) | 6.90% | 7.10% | 9.50% | 10.70% | 8.30% | 6.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 6.76% | 8.39% | 12.99% | 11.19% | 10.17% | 39.23% |
FCF Yield | 1.06% | 1.31% | 4.45% | 10.11% | 9.07% | 6.49% |
Dividend Yield | 3.09% | 3.83% | 3.89% | 3.14% | 3.07% | 2.74% |
Payout Ratio | 45.62% | 46.08% | 29.57% | 25.06% | 24.66% | 6.42% |
Buyback Yield / Dilution | 3.70% | 2.45% | 7.17% | 0.58% | -0.02% | -0.02% |
Total Shareholder Return | 6.77% | 6.28% | 11.06% | 3.72% | 3.05% | 2.72% |